NCT07129226 Musculoskeletal Cancers Remote Monitoring and Care
| NCT ID | NCT07129226 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Case Comprehensive Cancer Center |
| Condition | Osteosarcoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-11 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-02-11 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.
Eligibility Criteria
Inclusion Criteria: * primary sarcoma or metastatic bone disease of the lower extremities or pelvis. * undergoing evaluation for (or have recently undergone) non-surgical or surgical intervention. * recent history of home ambulation. Exclusion Criteria: * under 18 years of age at the time of study enrolment * inability to comprehend consent form and give informed consent * no access to a smartphone (iOS or Android) to interface with watch application * tattoos located on the skin of the wrist or forearm where the watch will be placed or other skin conditions preventing adequate sensor function * amputation or other disease of the arm or skin that prevents wear of a smart-watch device * inability to tolerate watch for at least 12 hours per day on at least 80% of days in a four-week period
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07129226 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteosarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07129226 currently recruiting?
Yes, NCT07129226 is actively recruiting participants. Contact the research team at burkez@ccf.org for enrollment information.
Where is the NCT07129226 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT07129226 clinical trial?
NCT07129226 is sponsored by Case Comprehensive Cancer Center. The trial plans to enroll 60 participants.